Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2011 Mar 1;121(3):1222. doi: 10.1172/JCI46407

Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

Amie S Corbin, Anupriya Agarwal, Marc Loriaux, Jorge Cortes, Michael W Deininger, Brian J Druker
PMCID: PMC3049387

Original citation: J. Clin. Invest. 2011;121(1):396–409. doi:10.1172/JCI35721.

Citation for this erratum: J. Clin. Invest. 2011;121(3):1222. doi:10.1172/JCI46407.

During the preparation of this manuscript, Figure 2D was inadvertently mislabeled. The correct figure appears below.

Figure 2.

Figure 2

The JCI regrets the error.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES